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ABSTRACT
Background: The purpose of this investigation was to test the feasibility of a home-based moderate-intensity
physical activity (MPA) program for people living with HIV/AIDS (PLWHA) currently taking antiretroviral therapy
(ART).
Methods: 68 participants recruited for a 9-month home-based PA intervention aimed to reduce risk factors of
cardiovascular disease for PLWHA taking ART. All participants received an educational weight loss workbook and a
pedometer for self-monitoring of physical activity. The intervention group received elastic Therabands® for strength
training in addition to telephone based behavioural coaching. Clinical assessments were conducted at baseline and
each follow-up which also included psychometric questionnaires and PA levels via the SenseWear® armband
accelerometer.
Results: Of the 57 completing the study, 29 of those were in the intervention group and 28 were in the standard care
group. Results show that the home-based PA intervention was not successful in increasing the total amount of MPA
for PLWHA. However there was a trend (p=0.08) of decreasing sedentary time. In a secondary analysis those who
increased PA by >10% observed decreases in waist circumference and improved functioning at 18 weeks. None of the
changes observed were significant after controlling for all potential confounders.
Conclusions: A home-based exercise approach with telephone-based coaching may not be a feasible method for
increasing MPA among PLWHA. Slight decreases in sedentary time indicate some positive changes in activity habits.
A possible strategy to improve studies similar to this is to incorporate a group based social interaction each week
similar to that of a support group.
Keywords: Community intervention, Randomized clinical trial, HIV, Physical Activity, Exercise, Self-care

INTRODUCTION
With the success of antiretroviral therapy (ART)
extending the life of people living with HIV/AIDS
(PLWHA), there has emerged an aging HIV population
and the long term consequences associated with ART

toxicity. These consequences primarily affect metabolic
processes often resulting in conditions similar to that of
metabolic syndrome.1,2 For example, protease inhibitors
have been shown to increase circulating blood lipids (i.e.
triglycerides, cholesterol, etc.) and cause a pattern of
abnormal fat deposition known as lipodystrophy -
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resulting in central fat accumulation. Other classes of
antiretrovirals are known to cause gastrointestinal and
metabolic consequences. Evidence has shown that the
risk for cardiovascular and diabetes related complications
increases significantly for every year a person is taking
ART.1,3
Physical activity has been widely accepted as a way to
reduce the incidence and risk of cardiovascular disease
and diabetes in the general population as well as
PLWHA.4-6 Physical activity is especially important to
PLWHA because the side effects associated with ART
can have a synergistic effect on lifestyle choices such as
sedentary living, unhealthy diets, and other determinants
of chronic disease. Routine physical activity could be
successful in reducing some of the side effects of HIV
infection/treatment and help self-manage the disease
while improving quality of life.

There is a growing body of evidence suggesting plwha
can achieve similar benefits in routine physical activity
commonly observed in the general population.7,11,18-20 The
use of a home-based physical activity intervention in
other clinical populations has successfully increased the
amount of daily physical activity accumulated when
compared to a control group.12,21,22 These programs
incorporated moderate-intensity physical activity, which
has been shown to be safe for clinical populations with
functional limitations.23,24 Similar physical activity
interventions are needed that can improve selfmanagement of metabolic conditions among PLWHA
taking art. The purpose of this study was to evaluate the
feasibility of a home-based physical activity intervention
aimed to increase moderate intensity physical activity and
reduce the incidence of cardiometabolic risk factors
among PLWHA.
METHODS

Routine physical activity has proven benefits in general
and clinical populations.4,7-13 Many of the physiological
benefits of activity are a direct result of metabolic
improvements (i.e. improved lipid panel, reduced waist
circumference and body fat, etc.) with long-term
improvements in cardiorespiratory health. Randomized
controlled trials of physical activity interventions have
shown decreases in body weight and visceral fat
accumulation, increased HDL cholesterol, decreased
triglycerides, and improved insulin sensitivity.9,14,15 These
studies are of various lengths with some lasting as little as
6-8 weeks and others showing benefits from year-long
interventions. What is unclear, however, is whether
PLWHA on ART intervention will benefit similarly from
a physical activity intervention. Because the rate of HIV
infection continues to increase in low-income
populations, it is important that cost-effective
interventions aimed at increasing physical activity are
identified and implemented. The increased number of
barriers to physical activity among many PLWHA
requires the development of effective interventions that
can be provided to large numbers at a low cost.

Participants
Study participants were recruited from local physicians,
clinics, and HIV/AIDS support groups in the greater
Columbia and Charleston, SC areas. There were 68
participants enrolled in the study and randomized into
one of two groups. For a complete list of the inclusion
and exclusion criteria see Table 1. Out of the initial 68
participants who were randomized, 62 completed the 18
week data collection period, and 57 completed the full 36
week study. There were six outliers identified at baseline
leaving a total of 62 participants for the final intent-totreat data analysis. Outliers were determined according to
baseline moderate-intensity physical activity values that
were 3 standard deviations higher or lower than the total
average. Figure 1 provides a schematic of participant
involvement through randomization and 36 week followup. The detailed description of the study methodologies
and participant recruitment for this study has been
published previously.25
Randomization

A number of studies demonstrate the effectiveness of
community-based physical activity interventions.8,12,16
These interventions range from group-based classroom
activities that emphasize behavior modification and
education all the way to simple home-based approaches
that incorporate weekly or bi-weekly telephone calls from
a trained health educator. These strategies have been
shown to be effective in a range of populations. Similar
home-based activity programs have targeted healthy
populations as well as a variety of clinical populations
such as those with heart failure, cancer, sporadic
inclusion body myositis, chronic obstructive pulmonary
disorder, and outcomes associated with various
inflammatory responses.12,13,17 To date, there have been
no published investigations that incorporate a homebased exercise approach for PLWHA.

After completion of baseline assessments all participants
were randomized into one of two groups: 1) Home-based
physical activity intervention or 2) standard care. Both
groups received an evidence-based book on healthful
eating and regular physical activity and a pedometer.26
Those randomized into the intervention group received a
one-on-one physical activity training session from a
trained interventionist to further explain participant
expectations. The training session provided an overview
of what constitutes physical activity, benefits of physical
activity, different types of physical activity, current
physical activity recommendations, tips for starting a
physical activity program and proper use of the activity
log. Additionally, the session included a demonstration
for use of the elastic Thera-bands® for strength training.
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Intervention

Non-exercise Standard Care Group

Two interventionists were trained by a clinical
psychologist with expertise in behavioral interventions to
implement the Active Choices program (developed at
Stanford University). Active Choices is a home-based
physical activity program that uses theoretically-based
strategies to help participants make lifestyle changes and
is based on both social cognitive theory and the
transtheoretical model.27 The intervention began with a
60-minute individual face-to-face session in which
rapport was established; the program and expectations
were described; a physical activity and diet history was
taken; explanation of realistic, specific, and measurable
short-term and long-term goals was addressed; safety
information was provided; instructions for wearing a
pedometer was given; self-monitoring tools (pedometer
and log) were distributed; and a schedule for follow-up
telephone calls was set. In addition to the education
session the health educator worked with each participant
to help them establish reasonable short term goals that
would eventually lead up to a common long term goal
among the participants (> 150 minutes of routine
moderate intensity physical activity per week).25

Participants in the standard care group received the same
educational material and weight loss manual as those
randomized to the physical activity group. Physical
activity habits were monitored throughout the study for
participants randomized to the standard care group in the
same manner as for the intervention group using the
SenseWear® armband. One potential problem in this
group was the possibility of participants losing interest in
the study because they were assigned to a “control”
group. We have been successful in reducing standard
care group dropout in previous studies by maintaining
telephone contact with standard care group participants.
In this study, we initiated contact with the standard care
group participants by telephone every two weeks to
update health status, maintain current contact
information, and emphasized the importance of their
participation for a successful study.

Figure 1: CONSORT flow diagram.

Outcome variables
The primary outcome of interest for this investigation
was moderate-intensity physical activity as measured by
the Sensewear® armband. This measurement was used as
an index of program adherence and total accumulation of
daily physical activity. Using tri-accelerometry
technology augmented by 2 heat sensors (a thermistorbased skin surface sensor and a proprietary heat flux
sensor), and a galvanic skin response sensor, the device is
able to accurately measure and record total energy
expenditure, and also measures activity intensity. The 4
internal sensors turn on the monitor when detecting skin
contact and measures total time the armband was worn,
daily energy expenditure, step count, sleep efficiency,
and the intensity, duration, and frequency of physical
activity bouts.
All arm band data were analyzed by computer-based
software using demographic information (gender, age,
height, and weight at prior assessment) and proprietary
algorithms. Validity of armband energy expenditure
estimates has been reported in several conditions
including resting, exercise (i.e. treadmill and cycle
ergometer), and free-living conditions (i.e. physical
activity and exercise).28,29 St-Onge et al. found that when
comparing the armband to doubly labeled water daily
energy expenditure had an interclass correlation of 0.81
(P < 0.01) between the two methods.30 When comparing
the armband to the Intelligent Device for Estimating
Energy Expenditure and Activity (IDEEA) Welk et al.
showed comparable results between the armband and
IDEEA when estimating energy expenditure and PA.29
Participants were required to wear the armband for a
minimum of 10 hours on 4 separate days for the armband
data to be considered valid. Secondary outcomes included
physiological and psychological variables, such as
cardiorespiratory fitness (VO2), body composition, full
blood lipid panel, serum C - reactive protein (CRP),
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interleukin-6 (IL-6), depression, anxiety, stress, and
health-related quality of life.

in both the general population (.85) and in patient
populations (.90).36

Testing procedures

Blood Sampling and Analyses

Graded exercise stress test: Following a medical
examination including evaluation of family and personal
medical history, resting blood pressure, and resting ECG
evaluation, each participant completed a graded exercise
treadmill test (GXT). The GXT was used to screen for
abnormal physiological responses to exercise, including
blood pressure and ECG responses, and for determining
the participant’s current level of cardiorespiratory fitness.
The test was terminated either at volitional exhaustion or
at observation of abnormal responses that are
contraindications for exercise. This test has been found to
be highly reproducible with a high sensitivity to changes
in VO2 peak.31

Blood draws were performed following an 8 hour fast at
baseline, 18 weeks, and 36 weeks. Participants were
asked to refrain from taking aspirin and other antiinflammatory medications for 48 hours prior to the blood
draw. Twenty milliliters of whole venous blood was
drawn into standard vacutainer tubes by trained
personnel. Standard separation procedures were used for
collection of serum and plasma. Samples were stored at 80º C until ready for analysis. The blood components of
interest were measured in duplicate by LabCorp® clinical
trials division. All samples were analyzed by a LabCorp
professional at a central location that undergoes rigorous
quality assurance testing to deliver high accuracy and
reliability in the results.

Body mass index and visceral fat: Anthropomorphic
measurements were made using standard laboratory
equipment. Height and weight were used to determine
body mass index (BMI, weight in kg/height in meters2) as
an index of total body fat. Waist circumference (WC) was
measured as an index of visceral fat. Waist circumference
is only an indirect measure of visceral fat, but budget
constraints preclude more direct measurement of visceral
fat.32
Self-report questionnaires
Perceived stress scale (PSS): The 10-item PSS assesses
the degree to which an individual finds life events
unpredictable, uncontrollable, or overwhelming.33
Internal consistency has been demonstrated by a
Cronbach’s alpha of 0.78.33 Validity of the PSS is
supported by significant correlations with greater helpseeking, poorer health, more health service utilization,
and poorer life satisfaction.33
MOS 36-item short-form health survey (SF-36): The SF36 is a widely used and validated self-report measure of
health-related quality of life.34 It consists of eight health
concepts including physical function, social function,
pain, mental health, energy/fatigue, general health
perceptions, role limitations due to physical problems,
and role limitations due to emotional problems. The SF36 can be divided into the two parts: the Mental
Composite Score (MCS) and the Physical Composite
Score (PCS). The internal consistency reliability
coefficients are high for its eight scales and ranges from
0.78 to 0.93.35
Centers for epidemiologic studies-depression (CES-D):
The 20-item CES-D is a widely used and validated selfreport measure of depressive symptoms.36 Components of
the CES-D include depressed mood, feelings of guilt and
worthlessness, feelings of hopelessness and helplessness,
psychomotor retardation, loss of appetite, and sleep
disturbance. The CES-D has a high internal consistency

Statistical analyses
We conducted an intent-to-treat analysis to test the
feasibility of this home-based study. Missing
observations were imputed into the dataset by the last
observation carried forward method. Outliers were
identified as participants who accumulated more than 3
standard deviations from the sample mean of moderate
intensity physical activity at baseline and removed from
the dataset. All analyses were performed using SPSS
statistical software. Treatment effects were evaluated
using a two way ANOVA by conducting a repeated
measure general linear model controlling for age, gender,
VO2, and baseline measures. Analyses were performed
on all outcome variables and accelerometer data. In a
secondary data analysis to determine changes in
secondary outcomes participants were divided into one of
two groups according to changes in physical activity.
Those in group 1 increased their average minutes per day
of moderate intensity physical activity by more than 10%,
whereas group 2 included the participants who stayed
within 10% or less of their daily physical activity average
measured at baseline and the 18 week follow-up. The
same groups were then created according to changes in
physical activity from baseline to 36 week follow-up.
Differences within and between groups were conducted
in a similar manner previously described but also
controlled for group assignment (intervention or standard
care).
RESULTS
At baseline there were no significant differences between
intervention and the standard care group for any
demographic, medical characteristics, or outcome
variables. All participants were currently taking a
combination antiretroviral regimen and none reported
changes in medications throughout the study duration.
The majority of participants (54%) were females and
African-American (82%), with a self-reported income
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less than $30,000 (69%). The average age was 47.1±9.4
years. Table 2 shows the baseline values of each outcome
variable. The mean duration of moderate intensity
activity for all participants was 91.6±77.8 minutes per
day and average sedentary time was 881.9±403.5 minutes
per day. No significant differences were found within or
between groups at the 18 week or 36 week time points for
any of the measured variables as seen in Table 2.

significantly decreased (p = 0.023) for those who
increased their daily physical activity at 18 weeks, but no
difference was observed at 36 weeks. As expected there
were also significant changes in moderate intensity
physical activity and sedentary time for both groups at
each time point. No significant differences were observed
among the other physiological variables. No significant
differences were observed in the psychological variables.

Tables 3.1 and 3.2 show the results of the secondary data
analysis in which participants were separated into groups
according to changes in physical activity. Those who
increased their activity levels by 10% or more showed a
decreasing trend in waist circumference that barely
reached significance (p = 0.05) at the 18 week time point,
but not 36 weeks. Systolic blood pressure also

A decreasing trend was observed in role functioning and
physical health of the intervention group at 18 weeks, but
this did not continue at 36 weeks. A reduction in pain was
seen at 36 weeks in the intervention group; role
limitations due to emotional health at 18 weeks also
exhibited a downward trend. After controlling for
potential confounders, none of the trends were
statistically significant.

Table 1: Inclusion and exclusion criteria.
Inclusion Criteria








Age 18 years and older
Medical diagnosis of HIV-1 positive serostatus
Sedentary lifestyle: not actively exercising ≥ 3 d·wk-1 for 20 min per session
Stable, DHHS-approved ART regimen for previous 3 months, with HIV viral load below 75 copies/mL
Capable of performing the required exercise regimen
Have daily access to a telephone for approximately 10 months
Capacity and willingness to provide informed consent and accept randomized group assignment

Exclusion Criteria

Temporary Exclusion Criteria















Individuals who have a clinical history strongly
suggestive of Type 1 diabetes.
History of serious arrhythmias, cardiomyopathy,
congestive heart failure, stroke or transient ischemic
cerebral attacks, peripheral vascular disease with
intermittent claudication, myocardial infarction, or
CABG.
Malignancies in the past 5 years, except therapeutically
controlled skin cancer.
Plans to be away > 4 weeks in the next 9 months
Score of 5 or greater on the DAST or MAST
(signifying excessive use of drugs or alcohol).
Weight loss in excess of 10% body weight in previous
12 weeks.
Chronic or recurrent respiratory, gastrointestinal,
neuromuscular, neurological, or psychiatric conditions.
Inflammatory-related conditions such as collagen
disorders.
Any other medical condition or disease that is lifethreatening or that can interfere with or be aggravated
by exercise.









Total cholesterol 240 mg/dl with LDL-C 160
mg/dl or TG levels 300 mg/dl. Note: Individuals
on cholesterol lowering medications but meeting
blood lipid requirements are eligible.
Resting blood pressure >160 systolic and/or 90
diastolic. Note: Individuals on blood pressure
medications but meeting blood pressure criteria are
eligible.
HbA1c 11%. Individuals whose HbA1c exceeds
this level will be recommended to seek treatment
immediately. Such individuals may be re-screened
after three months to re-assess HbA1c eligibility.
Current opportunistic infection at the time of
screening.
Participation in another intervention trial.
Other temporary intervening event, such as sick
spouse, bereavement, or recent move.
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Table 2: Results of measured outcomes.
Variable
Baseline
Weight in pounds, Mean ± SD
Standard Care
190.68 ± 49.79
Intervention
192.36 ± 40.25
BMI (kg/m2), Mean ± SD
Standard Care
30.88 ± 8.39
Intervention
30.29 ± 4.85
Waist circumference, Mean ± SD
Standard Care
99.47 ± 18.70
Intervention
99.08 ± 12.43
Blood Pressure, Mean ± SD
Systolic (mmHg)
Standard Care
129 ± 15
Intervention
128 ± 15
Diastolic (mmHg)
Standard Care
82 ± 11
Intervention
82 ± 9
Fasting blood analysis, Mean ± SD
Cholesterol (mg/dL)
Standard Care
172.82 ± 33.58
Intervention
199.94 ± 61.09
Triglycerides (mg/dL)
Standard Care
116.18 ± 68.44
Intervention
179.94 ± 189.19
LDL (mg/dL)
Standard Care
100.71 ± 28.64
Intervention
116.07 ± 39.78
HDL (mg/dL)
Standard Care
48.76 ± 12.59
Intervention
44.50 ± 22.75
VLDL (mg/dL)
Standard Care
23.35 ± 13.65
Intervention
27.07 ± 12.46
Glucose (mg/dL)
Standard Care
116.41 ± 40.63
Intervention
116.31 ± 59.45
C-Reactive Protein (mg/L)
Standard Care
6.62 ± 6.89
Intervention
4.53 ± 5.10
Interleukin-6 (pg/mL)
Standard Care
4.77 ± 2.11
Intervention
3.00 ± 1.58
PA Outcomes (Average minutes per day)
MVPA
Standard Care
93.35 ± 92.51
Intervention
89.90 ± 63.14
Light PA
Standard Care
221.23 ± 126.89
Intervention
190.62 ± 71.32
Sedentary
Standard Care
838.32 ± 249.61
Intervention
925.48 ± 153.86

18 weeks

36 weeks

p value

195.65 ± 53.86
193.16 ± 41.02

195.74 ± 53.42
196.01 ± 41.72

0.94
0.96

31.11 ± 8.73
30.28 ± 4.43

31.33 ± 9.22
31.43 ± 5.50

0.99
0.97

100.63 ± 18.31
96.31 ± 17.75

100.76 ± 18.77
101.64 ± 14.28

0.97
0.55

125 ± 12
124 ± 13

129 ± 19
125 ± 14

0.66
0.58

82 ± 10
78 ± 8

83 ± 12
82 ± 10

0.95
0.35

174.29 ± 36.43
199.90 ± 40.08

183.94 ± 31.35
205.69 ± 39.49

0.59
0.94

145.82 ± 122.64
188.40 ± 123.30

138.63 ± 147.78
168.23 ± 107.30

0.75
0.95

99.06 ± 31.21
122.89 ± 39.76

106.60 ± 29.15
122.17 ± 34.75

0.76
0.88

50.65 ± 13.36
47.40 ± 19.84

51.81 ± 13.13
48.69 ± 21.50

0.79
0.87

24.88 ± 17.69
32.56 ± 18.86

20.87 ± 12.28
29.75 ± 16.85

0.75
0.72

119.65 ± 89.02
113.40 ± 63.47

100.75 ± 21.94
85.52 ± 30.36

0.62
0.27

5.00 ± 4.75
4.27 ± 3.23

4.04 ± 4.36
5.29 ± 5.17

0.39
0.86

3.34 ± 2.45
3.16 ± 2.10

4.30 ± 2.77
11.86 ± 33.14

0.25
0.43

89.59 ± 79.29
83.16 ± 72.23

96.36 ± 80.33
79.26 ± 64.15

0.96
0.88

203.36 ± 84.41
181.74 ± 74.79

230.82 ± 114.30
198.16 ± 93.20

0.71
0.82

848.23 ± 231.70
787.37 ± 232.04

808.05 ± 274.80
816.26 ± 224.90

0.86
0.08

Steps (Average per day)
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Standard Care

5905.55 ± 2944.37

6179.47 ± 2865.38

6610.17 ± 3886.32

0.14

Intervention
5870.37 ± 2893.44
Sleep Metrics (Average hours per day)
Total sleep time
Standard Care
4.41 ± 1.64
Intervention
4.99 ± 1.69
Sleep efficiency (%)
Standard Care
73.44 ± 10.72
Intervention
73.71± 13.30

5285.38 ± 2483.99

5769.52 ± 3724.28

0.77

4.32 ± 2.07
3.92 ± 2.29

4.36 ± 1.75
4.43 ± 2.45

0.99
0.29

73.96 ± 8.72
72.75 ± 16.79

75.84 ± 8.61
71.47 ± 12.49

0.64
0.87

Table 3.1: Physical activity changes from baseline to 18 weeks.
Variable
BMI (kg/m2), Mean ± SD
Standard Care
Intervention
Waist circumference, Mean ± SD
Standard Care
Intervention
Blood Pressure, Mean ± SD
Systolic (mmHg)
Standard Care
Intervention
Diastolic (mmHg)
Standard Care
Intervention
Activity Monitor Outcomes, Mean ± SD
Measured EE
Standard Care
Intervention
Steps
Standard Care
Intervention
Sedentary Time
Standard Care
Intervention
Light Activity
Standard Care
Intervention
Moderate Activity
Standard Care
Intervention
Vigorous Activity
Standard Care
Intervention
Sleep Hours
Standard Care
Intervention
Fasting blood analysis, Mean ± SD
Cholesterol (mg/dL)
Standard Care
Intervention
Triglycerides (mg/dL)
Standard Care
Intervention

Baseline

18 Weeks

P value

30.92 ± 6.14
32.26 ± 5.14

31.41 ± 6.15
31.99 ± 5.50

0.12
0.23

100.15 ± 15.23
104.11 ± 13.53

99.35 ± 17.35
102.89 ± 12.68

0.33
0.05

127 ± 16
130 ± 16

124 ± 11
124 ± 80

0.11
0.03

82 ± 4
84 ± 9

80 ± 8
80 ± 10

0.16
0.09

2280.87 ± 712.93
2289.42 ± 500.32

2094.54 ± 581.93
2244.55 ± 556.19

<0.001
0.35

6106.75 ± 4025.09
5540.08 ± 2839.96

5236.41 ± 2684.68
6331.07 ± 2890.79

0.004
0.03

855.05 ± 167.62
912.58 ± 133.39

818.61 ± 200.87
785.05 ± 188.57

0.04
0.008

180.81 ± 38.16
202.75 ± 60.87

172.23 ± 44.47
215.06 ± 75.71

0.25
0.28

82.16 ± 71.64
59.00 ± 58.10

67.82 ± 54.37
89.16 ± 64.77

0.001
<0.001

5.27 ± 2.53
4.25 ± 2.39

2.88 ± 1.39
5.43 ± 4.38

0.06
0.12

4.38 ± 1.29
4.78 ± 1.23

5.18 ± 1.53
4.05 ± 1.88

0.17
0.04

182.94 ± 30.29
194.25 ± 35.83

180.10 ± 40.44
191.65 ± 35.08

0.31
0.34

160.81 ± 93.83
140.70 ± 67.66

142.39 ± 112.24
158.26 ± 119.70

0.21
0.24
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LDL (mg/dL)
Standard Care
Intervention
HDL (mg/dL)
Standard Care
Intervention
VLDL (mg/dL)
Standard Care
Intervention
Glucose (mg/dL)
Standard Care
Intervention
C-Reactive Protein (mg/L)
Standard Care
Intervention
Interleukin-6 (pg/mL)
Standard Care
Intervention
Questionnaires
Perceived Stress
Standard Care
Intervention
CESD
Standard Care
Intervention
SF-36 (Quality of Life)
Physical Functioning
Standard Care
Intervention
Role Limitations (Physical Health)
Standard Care
Intervention
Role Limitations (Emotional Health)
Standard
Intervention
Energy/Fatigue
Standard
Intervention
Mental Health
Standard Care
Intervention
Social Function
Standard Care
Intervention
Pain
Standard Care
Intervention
General Health
Standard Care
Intervention

104.03 ± 36.36
119.61 ± 38.54

103.13 ± 37.17
111.13 ± 38.80

0.38
0.26

46.19 ± 13.89
46.48 ± 14.18

49.23 ± 14.39
50.74 ± 14.05

0.19
0.09

28.58 ± 18.89
28.26 ± 13.46

27.68 ± 17.71
29.48 ± 17.12

0.35
0.13

110.19 ± 69.27
109.09 ± 43.15

110.26 ± 68.55
116.57 ± 93.59

0.49
0.28

5.77 ± 6.24
4.85 ± 5.38

5.72 ± 5.79
4.23 ± 3.07

0.46
0.17

4.30 ± 1.27
4.20 ± 2.21

4.46 ± 1.33
3.89 ± 2.08

0.46
0.16

14.84 ± 2.54
16.59 ± 3.74

15.66 ± 3.16
18.23 ± 4.25

0.72
0.16

15.15 ± 6.25
11.85 ± 17.57

14.13 ± 6.25
17.57 ± 4.98

0.49
0.06

81.32 ± 5.63
79.77 ± 3.20

78.55 ± 6.41
65.31 ± 2.38

0.32
0.03

76.97 ± 5.19
83.33 ± 5.57

32.89 ± 4.12
34.38 ± 7.79

0.08
0.05

79.82 ± 5.83
79.17 ± 6.89

25.43 ± 5.82
41.67 ± 7.84

0.001
0.005

64.52 ± 3.27
62.29 ± 3.88

62.57 ± 3.59
60.63 ± 4.04

0.92
0.86

72.21 ± 3.09
70.92 ± 3.57

70.92 ± 3.57
67.25 ± 3.92

0.65
0.07

76.97 ± 3.93
77.60 ± 4.05

73.31 ± 4.44
66.67 ± 6.34

0.24
0.09

75.21 ± 3.87
76.35 ± 4.47

74.14 ± 4.20
65.31 ± 5.51

0.72
0.303

64.21 ± 3.66
61.67 ± 4.94

67.31 ± 3.45
60.21 ± 4.13

0.11
0.66
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Table 3.2: Physical activity changes from baseline to 36 weeks.
Variable
BMI (kg/m2), Mean ± SD
Standard Care
Intervention
Waist circumference, Mean ± SD
Standard Care
Intervention
Blood Pressure, Mean ± SD
Systolic (mmHg)
Standard Care
Intervention
Diastolic (mmHg)
Standard Care
Intervention
Activity Monitor Outcomes, Mean ± SD
Measured EE
Standard Care
Intervention
Steps
Standard Care
Intervention
Sedentary Time
Standard Care
Intervention
Light Activity
Standard Care
Intervention
Moderate Activity
Standard Care
Intervention
Vigorous Activity
Standard Care
Intervention
Sleep Hours
Standard Care
Intervention
Fasting blood analysis, Mean ± SD
Cholesterol (mg/dL)
Standard Care
Intervention
Triglycerides (mg/dL)
Standard Care

Baseline

36 weeks

p value

31.47 ± 6.08
30.18 ± 5.23

32.16 ± 7.35
30.11 ± 5.31

0.23
0.44

101.49 ± 13.02
99.30 ± 14.27

102.24 ± 15.15
99.17 ± 15.48

0.17
0.47

127 ± 18.82
130.00 ± 11.39

126 ± 17.43
128.00 ± 20.49

0.27
0.38

83 ± 10.5
83.00 ± 6.36

82 ± 10.17
85.00 ± 11.37

0.16
0.27

2273.37 ± 639.32
2338.76 ± 543.88

2142.65 ± 475.44
2583.92 ± 547.50

0.02
0.004

5734.45 ± 3464.75
6459.52 ± 2918.25

5498.74 ± 2643.26
9214.95 ± 3915.20

0.14
0.02

945.68 ± 152.83
890.00 ± 121.82

895.74 ± 246.84
779.83 ± 145.64

0.02
0.035

185.59 ± 59.75
207.33 ± 61.56

193.61 ± 73.17
236.25 ± 86.83

0.13
0.07

72.76 ± 67.59
74.33 ± 62.07

65.53 ± 48.5
126.50 ± 79.31

0.004
0.001

5.17 ± 2.94
4.33 ± 68.55

2.6 ± 1.2
4.50 ± 3.35

0.03
0.38

4.46 ± 1.54
4.45 ± 1.03

4.15 ± 1.98
4.58 ± 1.71

0.07
0.31

184.42 ± 38.52
203.27 ± 47.45

194.5 ± 57.58
191.09 ± 40.24

0.42
0.19

132.69 ± 81.78

143.41 ± 139.77

0.18

Intervention

240.27 ± 55.42

194.55 ± 178.79

0.15

110.84 ± 40.95
107.00 ± 41.35

115.5 ± 47.75
102.11 ± 42.22

0.19
0.31

46.96 ± 12.37
45.55 ± 27.96

50.2 ± 12.16
49.45 ± 23.85

0.21
0.16

26.62 ± 16.4
25.56 ± 11.03

27.41 ± 12.64
24.33 ± 21.86

0.39
0.35

LDL (mg/dL)
Standard Care
Intervention
HDL (mg/dL)
Standard Care
Intervention
VLDL (mg/dL)
Standard Care
Intervention
Glucose (mg/dL)
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Standard Care
Intervention
C-Reactive Protein (mg/L)
Standard Care
Intervention
Interleukin-6 (pg/mL)
Standard Care
Intervention
Questionnaires
Perceived Stress
Standard Care
Intervention
CESD
Standard Care
Intervention
SF-36 (Quality of Life)
Physical Functioning
Standard Care
Intervention
Role Limitations (Physical Health)
Standard Care
Intervention
Role Limitations (Emotional Health)
Standard
Intervention
Energy/Fatigue
Standard
Intervention
Mental Health
Standard Care
Intervention
Social Function
Standard Care
Intervention
Pain
Standard Care
Intervention
General Health
Standard Care
Intervention
DISCUSSION

109.76 ± 64.75
104.09 ± 32.57

97.73 ± 26.22
92.00 ± 14.51

0.11
0.09

5.21 ± 5.22
5.09 ± 6.04

5.03 ± 5.1
2.95 ± 2.70

0.19
0.11

4.24 ± 2.25
3.93 ± 1.65

7.25 ± 2.03
3.25 ± 1.07

0.15
0.07

15.32 ± 1.08
16.17 ± 1.86

15.24 ± 0.98
17.58 ± 2.58

0.32
0.12

14.24 ± 1.65
12.33 ± 3.35

12.96 ± 1.39
18.50 ± 4.67

0.53
0.13

78.37 ± 3.36
90.52 ± 4.03

73.01 ± 3.89
75.74 ± 8.71

0.08
0.08

76.02 ± 2.85
91.67 ± 2.43

30.39 ± 4.66
25.00 ± 4.75

0.45
0.03

80.27 ± 7.34
75.00 ± 3.96

35.33 ± 5.51
30.56 ± 10.43

0.45
0.21

62.43 ± 2.94
68.75 ± 3.75

61.60 ± 3.16
64.58 ± 5.55

0.86
0.57

72.32 ± 2.70
75.00 ± 3.45

74.82 ± 2.73
71.67 ± 5.33

0.57
0.23

76.96 ± 3.16
80.21 ± 6.61

77.50 ± 3.94
68.75 ± 7.77

0.23
0.43

73.25 ± 3.36
85.63 ± 4.67

70.41 ± 3.76
61.25 ± 8.16

0.19
0.001

62.61 ± 3.31
65.83 ± 6.42

The purpose of this investigation was to test the
feasibility and short-term effectiveness of a 9-month
home-based physical activity intervention to increase
moderate-intensity physical activity and reduce cardiometabolic risk among PLWHA compared to standard
care. We found that compared to standard care, a homebased walking intervention was not effective for
increasing daily physical activity levels among PLWHA
who were not regularly active prior to the intervention.
Activity levels were measured at 18 and 36 weeks post
randomization and neither time point showed a
significant change in daily physical activity. Due to the
lack of increases in physical activity, it was not surprising
to observe no changes in cardio-metabolic risk factors.
These findings are conflicting with similar home-based

63.80 ± 2.92
0.49
71.25 ± 5.51
0.23
trials for different clinical populations such as breast
cancer survivors reported by Matthews et al.17
Matthews et al. found significant increases in physical
activity levels among breast cancer survivors completing
a similar home-based exercise program as this one.17
Similar to this study, Matthews and colleagues focused
on increasing activity levels of a previously sedentary
clinical population using a similar telephone-based
coaching and behavior modification technique. The
intervention resulted in a 12 MET-h/week increase
among breast cancer survivors and 76% of the women in
the intervention were active 5 days a week or more
during the final 4 weeks of the intervention. A major
difference between our study and the one by Matthews et
al was the length of the intervention (12 weeks compared
to 36). However when measured at 18 weeks, our
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population did not show any increases in daily physical
activity. Another possible explanation for the conflicting
results could be the population itself. PLWHA are known
to have inconsistent periods of good and bad health.
Depression and anxiety are also very common when
faced with a chronic condition like HIV making it that
much harder to be active consistently.12,37 In the study by
Matthews and colleagues they recruited survivors of
breast cancer. The women in that investigation were
possibly more focused on improving their health and
quality of life since they had just overcome a life
threatening condition such as cancer.12
Analysis of Increased Physical Activity
In a secondary data analysis we separated the participants
into one of two groups at both the 18 week and 36 week
follow-ups: 1) those who increased daily moderate
intensity physical activity minutes by more than 10%
compared to baseline, and 2) those who accumulated
10% or less of moderate intensity physical activity
compared to their baseline measurement. This was done
in an effort to test the effects of increased activity
particularly on markers of cardio-metabolic risk. What
we found were significant changes in two variables, both
of which are known risk factors for CVD. More
specifically, those who increased daily physical activity
saw a decrease in waist circumference and systolic blood
pressure. Although not significant, some individuals
experienced improved lipid profiles, such as increased
HDL cholesterol and decreased LDL cholesterol. These
findings are similar to what would be expected among
healthy individuals and would further indicate the
importance to identify simple and cost-effective
interventions that successfully increase physical activity
among PLWHA.
As presented in Table 3.1, there was a slight downward
trend at 18 weeks in most of the psychological variables,
including physical functioning, physical and emotional
health, energy/fatigue, mental and social health, pain, and
general health. At 36 weeks, a stronger downward trend
was observed for pain and emotional health; however
physical functioning, mental and social health,
energy/fatigue, and general health did not show
significant change. None of the changes observed were
significant after controlling for all potential confounders.
Various factors could have contributed to this lack of
significance. For example the length of time between
questionnaires and characteristics of the population are
possible reasons. The participants completed the profile
of mood states questionnaire a total of 3 times: baseline,
18 weeks, and 36 weeks. To observe a true relationship,
this should be completed multiple times throughout the
week and studied using an average of those results. Other
researchers have observed a trend between pain and
mood with exercise.37,38 Neidig et al saw a decrease in
depressive symptoms in HIV infected individuals after a
12 week exercise intervention using the CES-D and
POMS depression subscale.37 This group is known to

have multiple comorbidities, side effects to medications,
socioeconomic barriers, and psychosocial concerns.
A possible strategy to improve studies similar to this is to
incorporate a group based social interaction each week
similar to that of a support group. It also would be ideal
to include a type of “buddy system” or asking
participants to recruit a partner to exercise with them.
Studies have consistently shown the importance of social
support among physical activity and the social interaction
will often increase the chances of success when someone
is beginning a new workout program.39 Many of the
participants of this trial actually asked if such a system
was in place. Since this was a single-person study design,
it was explained to them that being paired with a partner
was not part of the study protocol, but it was encouraged
that they find a friend or loved one who might be able to
exercise with them.
One of the most significant findings of this study was
further evidence showing a strong inverse relationship
between waist circumference and increased physical
activity. In a previous article from this study, we showed
moderate intensity physical activity to be a significant
predictor for waist circumference.7 Although the
intervention itself was not successful in increasing
physical activity, when the sample was divided into
groups according to changes in physical activity, the data
showed that regardless of group assignment those who
significantly increased their daily physical activity
significantly decreased their waist circumference at the
18 week time point.
Strengths and limitations of the current study should be
taken into careful consideration and may explain some of
our findings, or lack thereof. The strengths included
recruiting an HIV population with almost equal numbers
of males and females, which allowed for comparing
possible gender differences of significant findings. It
should also be noted that this clinical trial incorporated a
randomized design of physically inactive HIV+ patients
and an analysis plan that utilized intent-to-treat
principles. The lack of significance of increased physical
activity for those randomized to the intervention group
would indicate that future studies should take a different
approach to increase daily physical activity of similar
populations. It should be noted that there are multiple
barriers PLWHA face that need to be taken into
consideration when developing future interventions
including socioeconomic, personal, social, and
environmental factors. Mgbere et al found numerous
barriers that can adversely affect care access: negative
perceptions of the health care system, longer wait time
for appointments, lack of flexibility in clinic hours, unmet
needs for child care, lack of access to a provider with
expertise in treating HIV, strained patient–provider
relationship, patient concerns about privacy, mandatory
insurance coverage, and multiple funding sources with
variable eligibility criteria. On the individual level, they
noted multiple barriers which prevent or decrease
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PLWHA from utilizing health care including mental
health issues and drug addictions, HIV stigma, limited
social support, unstable housing and transportation,
incarceration, undocumented immigrant status, and
avoidance and denial of HIV status.40 When separated
into groups according to change in physical activity, it
was observed that health benefits could be obtained
within 18 weeks for this specific population. In addition
to a randomized design, this study also incorporated
objective measures of physical activity and sedentary
behavior using the Sensewear® armband.
Several limitations should be noted as well. This
population was comprised primarily of AfricanAmericans from lower socio-economic status and
majority reported a yearly income less than $30,000. This
does not allow us to generalize the findings across other
races or individuals living with HIV with a higher yearly
income who may have access to other means for physical
activity such as gyms or home exercise equipment.
Although this investigation examined numerous
confounding variables, the lack of unmeasured covariates
cannot be ruled out. Some of these include weekly, or
even daily, health status and dietary intake. Another
covariate could potentially be chronic pain and/or
peripheral neuropathy which is very common among
PLWHA and known to limit activity levels.41 Other
limitations include the lack of dietary data and exercise
log to determine weekly adherence.
CONCLUSION
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